Sagar Chhangawala

Title: Sagar Chhangawala: Innovator in Cancer Prognostics

Introduction

Sagar Chhangawala is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the area of prognostic markers for pancreatic cancer. His innovative work aims to improve patient outcomes through advanced predictive technologies.

Latest Patents

Sagar Chhangawala holds a patent for an "ATAC-array for prediction of disease-free survival in pancreatic cancer." This patent describes an array-based assay that focuses on transposase-accessible chromatin and prognostic molecular markers for treatment-resistant and early recurrent cancer. The technology is designed to predict outcomes, such as the duration of disease-free survival, in cancer patients.

Career Highlights

Throughout his career, Sagar has worked with prestigious institutions, including Dartmouth College and Memorial Sloan Kettering Cancer Center. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Some of Sagar's notable coworkers include Steven D. Leach and Christina Leslie. Their collaborative efforts have contributed to advancements in cancer prognostics and treatment strategies.

Conclusion

Sagar Chhangawala's innovative work in cancer research and his patent for predicting disease-free survival in pancreatic cancer highlight his commitment to improving patient outcomes. His contributions to the field are invaluable and demonstrate the importance of innovation in medical science.